Literature DB >> 23196757

Evaluation of risk factors for venous thromboembolism in Chinese women with epithelial ovarian cancer.

Xiangxiang Wu1, Xiang Xue, Jie Tang, Xi Cheng, Wenjuan Tian, Rong Jiang, Rongyu Zang.   

Abstract

OBJECTIVE: Venous thromboembolism (VTE) is a life-threatening complication that often occurs in ovarian tumors. However, the risk factors for VTE are still undetermined.
METHODS: We retrospectively analyzed VTE occurrence and its potential risk factors in 254 Chinese patients with ovarian tumor at Fudan University Cancer Hospital from July 2007 to June 2011.
RESULTS: The VTE incidence was 7.1% (13/183) in epithelial ovarian cancer (EOC), and no VTE was found in ovarian borderline or benign tumor. D-dimer levels were significantly higher in EOC than in ovarian benign and borderline tumors. Furthermore, D-dimer levels increased with the advancement of EOC stages. Correlation analysis suggested that D-dimer levels were well correlated with platelet counting (PLT), prothrombin time (PT), white blood cell counting (WBC), cancer antigen (CA) 125, and CA153. Univariate logistic regression analysis found that D-dimer levels greater than 788 μg/L, PLT levels greater than 261 × 10(9)/L, PT greater than 11.7 seconds, CA125 greater than 760 U/mL, and ascites greater than 1500 mL are risk factors for VTE in EOC. Moreover, multivariate analysis grouped primary EOC, low differentiated grade, D-dimer greater than 788 μg/L, PT greater than 11.7 seconds, and CA125 greater than 760 U/mL as prediction factors for VTE.
CONCLUSIONS: In addition to D-dimer and ascites, high levels of PLT, PT, and CA125, which are highly correlated with D-dimer, are independent risk factors for VTE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23196757     DOI: 10.1097/IGC.0b013e318276dd87

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Association between Level of Tumor Markers and Development of VTE in Patients with Pancreatic, Colorectal and Ovarian Ca: Retrospective Case- Control Study in Two Community Hospitals.

Authors:  Nelly Awkar; Sawsan Amireh; Srijana Rai; Hamid Shaaban; Gunwant Guron; Michael Maroules
Journal:  Pathol Oncol Res       Date:  2017-05-04       Impact factor: 3.201

Review 2.  Clinical significance of plasma D-dimer in ovarian cancer: A meta-analysis.

Authors:  Jiacong Wu; Ziyi Fu; Guangquan Liu; Pengfei Xu; Juan Xu; Xuemei Jia
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

3.  The prevalence, risk factors, and prognostic value of venous thromboembolism in ovarian cancer patients receiving chemotherapy: a systematic review and meta-analysis.

Authors:  Lu Ye; Li Cai; Yonghui Fu; Debao Zhuang; Xiaoqing Hu; Youkun Jie
Journal:  World J Surg Oncol       Date:  2021-01-13       Impact factor: 2.754

Review 4.  D-Dimer elevation and adverse outcomes.

Authors:  Rim Halaby; Christopher J Popma; Ander Cohen; Gerald Chi; Marcelo Rodrigues Zacarkim; Gonzalo Romero; Samuel Z Goldhaber; Russell Hull; Adrian Hernandez; Robert Mentz; Robert Harrington; Gregory Lip; Frank Peacock; James Welker; Ignacio Martin-Loeches; Yazan Daaboul; Serge Korjian; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

5.  Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery.

Authors:  Ruidi Yu; Faridah Nansubuga; Jun Yang; Wencheng Ding; Kezhen Li; Danhui Weng; Peng Wu; Gang Chen; Ding Ma; Juncheng Wei
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.